1002423

Remington Davis Inc — FEI 1525385

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 27, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Columbus, OH (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance